< back / CU2007Edmonton

8:30	Welcome	Anatoly Langer, MD
Management of the Cardiovascular Patient in Your Office
8:35	The Role of ACE-I: Managing risk across the CV continuum	David Fitchett, MD
8:55	Managing ACS Patients: Importance of dual antiplatelet therapy	Robert Welsh, MD
9:15	How Low Do We Go and How Do We Achieve Aggressive Goals?	Gabor Gyenes, MD
9:35	Evolution of Statin Trials On Vulnerable Plaque	Robert Welsh, MD
10:05	Panel Discussion Additional Discussion Topic: When to look for 2° HT in the office	All faculty
10:35	Break
Management of Risk Factors
10:55	Evidence Supporting the CCS and CDA Dyslipidemia Guidelines	Anatoly Langer, MD
11:15	Overview of Smoking Cessation in Canada	Charl Els, MD
11:35	3 Minute Empowerment: How to motivate your patient to change any behaviour	Nigel Flook, MD
11:55	Optimal Management in the Treatment of Global Cardiovascular Risk: Result of ASCOT 2x2	Anatoly Langer, MD
12:15	Panel Discussion Additional Discussion Topic: Preventing stroke (coumadin vs. ASA, statin, etc)	All faculty
12:45	Lunch
New Targets in Outpatient Practice
13:30	Better BP Control: The earlier the better	Kailash Jindal, MD
13:50	Innovations in Hypertension Management:  Direct rennin inhibition	David Fitchett, MD
14:10	Exploration of Landmark CV Trials: HOPE to ONTARGET	Kailash Jindal, MD
14:30	The ABC's of ARB's for Hypertension	Zaheer Lakhani, MD
15:10	Panel Discussion Additional Discussion Topic: Work up of chest pain in the office	All faculty
15:40	Close

The Division of Continuous Professional Learning at the University of Alberta has approved this as an Accredited Group Learning Activity under Section 1 of the Framework of Continuing Professional Development options for the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

This program meets the accreditation criteria of The College of Family Physicians of Canada and has been accredited for up to 6 Mainpro-M1 credits.